A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer
- Issued Date
- 2021
- Type
- Article
- Publisher
- BRITISH JOURNAL OF CANCER
- Language
- 영어
- ISSN
- 0007-0920
- Citation Volume
- 124
- Citation Number
- 2
- Citation Start Page
- 383
- Citation End Page
- 390
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.